Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons

Developmental Brain Research

Volumn 139, Issue 1, 2002, Pages 73-86

  Newman, Mary B ^a   Kuo, Yen Ping ^b   Lukas, Ronald J ^b   Sanberg, Paul R ^a   Douglas Shytle, R ^a   McGrogan, Michael P ^c   Zigova, Tanja ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c Layton BioScience Inc   (United States)

Author keywords

hNT neuron; Immunocytochemistry; mRNA; Nicotinic receptor; NT2 cell

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA3; ACETYLCHOLINE RECEPTOR ALPHA4; ACETYLCHOLINE RECEPTOR ALPHA5; ACETYLCHOLINE RECEPTOR ALPHA6; ACETYLCHOLINE RECEPTOR ALPHA9; ACETYLCHOLINE RECEPTOR BETA2; ACETYLCHOLINE RECEPTOR BETA4; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN NT2; CELL STRAIN NT2N; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

BLOTTING, SOUTHERN; CELL LINE; COLORING AGENTS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 0037111254     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00513-8     Document Type: Article

References (70)

1. Albuquerque E.X., Pereira E.F., Castro N.G., Alkondon M., Reinhardt S., Schroder H., Maelicke A. Nicotinic receptor function in the mammalian central nervous system. Ann. NY Acad. Sci. 757:1995;48-72.
2. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:1984;285-293.
3. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab. Invest. 50:1984;147-162.
4. Aramakis V.B., Hsieh C.Y., Leslie F.M., Metherate R. A critical period for nicotine-induced disruption of synaptic development in rat auditory cortex. J. Neurosci. 20:2000;6106-6116.
5. Banerjee C., Nyengaard J.R., Wevers A., de Vos R.A., Jansen Steur E.N., Lindstrom J., Pilz K., Nowacki S., Bloch W., Schroder H. Cellular expression of α7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease - a stereological approach. Neurobiol. Dis. 7:2000;666-672.
6. Broide R.S., Robertson R.T., Leslie F.M. Regulation of α7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents. J. Neurosci. 16:1996;2956-2971.
7. Chuong C.M., Edelman G.M. Alterations in neural cell adhesion molecules during development of different regions of the nervous system. J. Neurosci. 4:1984;2354-2368.
8. Court J.A., Lloyd S., Johnson M., Griffiths M., Birdsall N.J., Piggott M.A., Oakley A.E., Ince P.G., Perry E.K., Perry R.H. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res. Dev. Brain Res. 101:1997;93-105.
9. Deutch A.Y., Holliday J., Roth R.H., Chun L.L., Hawrot E. Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc. Natl. Acad. Sci. USA. 84:1987;8697-8701.
10. Dineley-Miller K., Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, β4, are distributed in multiple areas of the rat central nervous system. Brain Res. Mol. Brain Res. 16:1992;339-344.
11. el-Bizri H., Clarke P.B. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br. J. Pharmacol. 111:1994;414-418.
12. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., Boulter J. α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. USA. 98:2001;3501-3506.
13. Fu Y., Matta S.G., Gao W., Brower V.G., Sharp B.M. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J. Pharmacol. Exp. Ther. 294:2000;458-465.
14. Getman D.K., Mutero A., Inoue K., Taylor P. Transcription factor repression and activation of the human acetylcholinesterase gene. J. Biol. Chem. 270:1995;23511-23519.
15. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
16. Guillemain I., Alonso G., Patey G., Privat A., Chaudieu I. Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. J. Comp. Neurol. 422:2000;380-395.
17. 3H]cytisine. Neuroscience. 62:1994;929-944.
18. Hellstrom-Lindahl E., Moore H., Nordberg A. Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists. J. Neurochem. 74:2000;777-784.
19. Hill J.A. Jr., Zoli M., Bourgeois J.P., Changeux J.P. Immunocytochemical localization of a neuronal nicotinic receptor: the β 2-subunit. J. Neurosci. 13:1993;1551-1568.
20. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol. 48:1995;280-287.
21. Iacovitti L., Stull N.D. Expression of tyrosine hydroxylase in newly differentiated neurons from a human cell line (hNT). Neuroreport. 8:1997;1471-1474.
22. Iacovitti L., Stull N.D., Jin H. Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line. Brain Res. 912:2001;99-104.
23. Karlin A., Akabas M.H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15:1995;1231-1244.
24. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
25. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A. Stimulation of α4 β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res. 792:1998;331-334.
26. Le Novere N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
27. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Ion Channels. 4:1996;377-450.
28. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 15:1997;193-222.
29. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 109:1996;125-137.
30. Llanes C., Collman R.G., Hrin R., Kolson D.L. Acetylcholinesterase expression in NTera 2 human neuronal cells: a model for developmental expression in the nervous system. J. Neurosci. Res. 42:1995;791-802.
31. Lobron C., Wevers A., Damgen K., Jeske A., Rontal D., Birtsch C., Heinemann S., Reinhardt S., Maelicke A., Schroder H. Cellular distribution in the rat telencephalon of mRNAs encoding for the α 3 and α 4 subunits of the nicotinic acetylcholine receptor. Brain Res. Mol. Brain Res. 30:1995;70-76.
32. Lukas R. Cell lines as models for studies of nicotinic acetylcholine receptors. Arneric S.P., Brioni J.D., Neuronal Nicotinic Receptors: Pharmacology and Therapeutics Opportunities. 1998;81-97 Wiley-Liss, New York.
33. Lukas R.J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34:1992;25-131.
34. Lukas R.J., Changeux J.P., Le Novere N., Albuquerque E.X., Balfour D.J., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51:1999;397-401.
35. Lustig L.R., Peng H., Hiel H., Yamamoto T., Fuchs P.A. Molecular cloning and mapping of the human nicotinic acetylcholine receptor α10 (CHRNA10). Genomics. 73:2001;272-283.
36. Maggio R., Riva M., Vaglini F., Fornai F., Molteni R., Armogida M., Racagni G., Corsini G.U. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J. Neurochem. 71:1998;2439-2446.
37. Martin-Ruiz C., Court J., Lee M., Piggott M., Johnson M., Ballard C., Kalaria R., Perry R., Perry E. Nicotinic receptors in dementia of Alzheimer. Lewy body and vascular types. Acta Neurol. Scand. Suppl. 176:2000;34-41.
38. McLane K.E., Wu X., Lindstrom J.M., Conti-Tronconi B.M. Epitope mapping of polyclonal and monoclonal antibodies against two α-bungarotoxin-binding α subunits from neuronal nicotinic receptors. J. Neuroimmunol. 38:1992;115-128.
39. Miyazono M., Lee V.M., Trojanowski J.Q. Proliferation, cell death, and neuronal differentiation in transplanted human embryonal carcinoma (NTera2) cells depend on the graft site in nude and severe combined immunodeficient mice. Lab. Invest. 73:1995;273-283.
40. Miyazono M., Nowell P.C., Finan J.L., Lee V.M., Trojanowski J.Q. Long-term integration and neuronal differentiation of human embryonal carcinoma cells (NTera-2) transplanted into the caudoputamen of nude mice. J. Comp. Neurol. 376:1996;603-613.
41. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Biol. Psychiatry. 49:2001;268-278.
42. Nordberg A., Lundqvist H., Hartvig P., Andersson J., Johansson M., Hellstrom-Lindahi E., Langstrom B. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dement Geriatr. Cogn. Disord. 8:1997;78-84.
43. Papke R.L. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41:1993;509-531.
44. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 61:2000;75-111.
45. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brown A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease. Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385-395.
46. Pleasure S.J., Lee V.M. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:1993;585-602.
47. Pleasure S.J., Page C., Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
48. Reuben M., Boye S., Clarke P.B. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically. Eur. J. Pharmacol. 393:2000;39-49.
49. 3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology. 39:2000;290-299.
50. Saporta S., Willing A.E., Colina L.O., Zigova T., Milliken M., Daadi M.M., Sanberg P.R. In vitro and in vivo characterization of hNT neuron neurotransmitter phenotypes. Brain Res. Bull. 53:2000;263-268.
51. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Patrick J., Steinbach J.H., Culp W., Brandt B.L. Clonal cell lines from the rat central nervous system. Nature. 249:1974;224-227.
52. 125I-neuronal bungarotoxin. J. Neurosci. 11:1991;287-297.
53. 3H]acetylcholine in rat brain. Mol. Pharmacol. 22:1982;56-62.
54. 3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience. 94:1999;685-696.
55. Sparks D.L., Beach T.G., Lukas R.J. Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations. Neurosci. Lett. 256:1998;151-154.
56. Terzano S., Court J.A., Fornasari D., Griffiths M., Spurden D.P., Lloyd S., Perry R.H., Perry E.K., Clementi F. Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Brain Res. Mol. Brain Res. 63:1998;72-78.
57. Trojanowski J.Q., Kleppner S.R., Hartley R.S., Miyazono M., Fraser N.W., Kesari S., Lee V.M. Transfectable and transplantable postmitotic human neurons: a potential 'platform' for gene therapy of nervous system diseases. Exp. Neurol. 144:1997;92-97.
58. Warpman U., Nordberg A. Epibatidine and ABT 418 reveal selective losses of α 4 β 2 nicotinic receptors in Alzheimer brains. NeuroReport. 6:1995;2419-2423.
59. Wevers A., Witter B., Moser N., Burghaus L., Banerjee C., Steinlein O.K., Schutz U., de Vos R.A., Steur E.N., Lindstrom J., Schroder H. Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis? Acta Neurol. Scand. Suppl. 176:2000;42-48.
60. Whitehouse P.J., Martino A.M., Marcus K.A., Zweig R.M., Singer H.S., Price D.L., Kellar K.J. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch. Neurol. 45:1988;722-724.
61. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38:1988;720-723.
62. Whiting P.J., Lindstrom J.M. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci. 8:1988;3395-3404.
63. Whiting P.J., Schoepfer R., Swanson L.W., Simmons D.M., Lindstrom J.M. Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors. Nature. 327:1987;515-518.
64. Winzer-Serhan U.H., Leslie F.M. Codistribution of nicotinic acetylcholine receptor subunit α3 and β4 mRNAs during rat brain development. J. Comp. Neurol. 386:1997;540-554.
65. Wolfe B.B., Yasuda R.P. Development of selective antisera for muscarinic cholinergic receptor subtypes. Ann. NY Acad. Sci. 757:1995;186-193.
66. Wonnacott S., Kaiser S., Mogg A., Soliakov L., Jones I.W. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393:2000;51-58.
67. Zigova T., Barroso L.F., Willing A.E., Saporta S., McGrogan M.P., Freeman T.B., Sanberg P.R. Dopaminergic phenotype of hNT cells in vitro. Brain Res. Dev. Brain Res. 122:2000;87-90.
68. Zigova T., Pencea V., Sanberg P.R., Luskin M.B. The properties of hNT cells following transplantation into the subventricular zone of the neonatal forebrain. Exp. Neurol. 163:2000;31-38.
69. Zigova T., Willing A.E., Tedesco E.M., Borlongan C.V., Saporta S., Snable G.L., Sanberg P.R. Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons. Exp. Neurol. 157:1999;251-258.
70. Zoli M., Le Novere N., Hill J.A. Jr., Changeux J.P. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci. 15:1995;1912-1939.